Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bufei Yishen Granule for Reducing Acute Exacerbation in GOLD Stage 3 or 4 COPD: A Randomized, Double-blind, Placebo Controlled Trial

NCT03976713 is registered in ClinicalTrials.gov with Henan University of Traditional Chinese Medicine as lead sponsor.

NCT NCT03976713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03976713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bufei Yishen Granule for Reducing Acute Exacerbation in GOLD Stage 3 or 4 COPD: A Randomized, Double-blind, Placebo Controlled Trial
Lead sponsor
Henan University of Traditional Chinese Medicine
Phase
Phase 3
Overall status
Unknown status
Start date
June 30, 2019
Completion date
December 31, 2020
Enrollment
348 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease